Your browser doesn't support javascript.
loading
Rotigotine is effective for depressive symptoms accompanying periodic limb movement disorder or restless legs syndrome.
Miura, Jun; Honma, Ken-Ichi; Honma, Sato.
Afiliação
  • Miura J; Sapporo Hanazono Hospital, 1-30 South 15 West 15, Chuo-ku, Sapporo, 0640915 Japan.
  • Honma KI; Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Japan.
  • Honma S; Present Address: Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 1578577 Japan.
Sleep Biol Rhythms ; 20(2): 315-317, 2022 Apr.
Article em En | MEDLINE | ID: mdl-38469260
ABSTRACT
We report two cases who had been diagnosed with major depression, but found to have periodic limb movement disorder (PLMD) or restless legs syndrome (RLS) as major disorder. Both patients had difficulties in occupational and/or daily lives. In neither case, antidepressants were effective in symptom remission. In contrast, rotigotine transdermal patch was effective not only for core symptoms of PLMD or RLS but also for accompanying depressive symptoms. Since PLMD and RLS are associated with dopaminergic dysfunction etiologically, a dopamine receptor agonist rotigotine might be a good choice for patients with PLMD or RLS accompanying depression.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article